scholarly journals Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

2019 ◽  
Vol 105 (1) ◽  
pp. S78 ◽  
Author(s):  
C. Tsien ◽  
S. Pugh ◽  
A.P. Dicker ◽  
J.J. Raizer ◽  
M.M. Matuszak ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Plan Quality ◽  
Randomized Phase Ii ◽  
Quality Report

scholarly journals ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi13-vi13
Author(s):  
Vinay Puduvalli ◽  
Jing Wu ◽  
Ying Yuan ◽  
Terri Armstrong ◽  
Jimin Wu ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

2017 ◽  
Vol 136 (1) ◽  
pp. 115-125 ◽  
Author(s):  
J. Duerinck ◽  
S. Du Four ◽  
F. Bouttens ◽  
C. Andre ◽  
V. Verschaeve ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii

scholarly journals AT-39A RANDOMIZED PHASE II TRIAL OF VANDETANIB (ZD6474) IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA

2014 ◽  
Vol 16 (suppl_5) ◽  
pp. v17-v17 ◽  
Author(s):  
Katharine McNeill ◽  
Fabio Iwamoto ◽  
Teri Kreisl ◽  
Joohee Sul ◽  
Joanna Shih ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii

scholarly journals A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

2018 ◽  
Vol 24 (4) ◽  
pp. 521-528 ◽  
Author(s):  
Alba A. Brandes ◽  
Miguel Gil‐Gil ◽  
Frank Saran ◽  
Antoine F. Carpentier ◽  
Anna K. Nowak ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Efficacy And Safety ◽  
Randomized Phase Ii

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2005-2005 ◽  
Author(s):  
Shiao-Pei S. Weathers ◽  
Stan Xiaosi Han ◽  
Diane D Liu ◽  
Charles A. Conrad ◽  
Mark R. Gilbert ◽  
...  
Keyword(s):  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Standard Dose ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii

scholarly journals ATCT-34BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB PLUS VORINOSTAT VERSUS BEVACIZUMAB ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA

2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v9.2-v9
Author(s):  
Jing Wu ◽  
Vinay K. Puduvalli ◽  
Ying Yuan ◽  
Terri Armstrong ◽  
Brenda Walker ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii

scholarly journals A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma

2016 ◽  
Vol 129 (3) ◽  
pp. 487-494 ◽  
Author(s):  
Shiao-Pei Weathers ◽  
Xiaosi Han ◽  
Diane D. Liu ◽  
Charles A. Conrad ◽  
Mark R. Gilbert ◽  
...  
Keyword(s):  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Standard Dose ◽  
Recurrent Glioblastoma ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document